R2 Technologies offers Glacial® Rx, a customizable CryoAesthetics® treatment that utilizes precision cooling to reduce inflammation and improve skin conditions. This clinically-proven platform addresses benign skin lesions while providing temporary relief from pain, swelling, and inflammation through tailored treatment plans based on individual patient biology.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals seek non-invasive cosmetic treatments to address skin inflammation and improve overall skin appearance. Existing solutions may not offer customizable treatment plans tailored to individual patient biology, potentially leading to suboptimal results.
Solution
R2 Technologies offers Glacial® Rx, a CryoAesthetics® platform that utilizes precision cooling to combat inflammation and rejuvenate skin. This clinically-proven technology allows providers to create personalized treatment plans based on each patient's unique skin biology. The platform's versatility and customizable modalities enable targeted treatment at precise temperatures and durations, aiming to optimize outcomes and patient comfort. Glacial® Rx addresses benign skin lesions while providing temporary relief from pain, swelling, and inflammation.
Target Audience
The primary target audience includes individuals seeking non-invasive cosmetic treatments for skin rejuvenation and inflammation reduction, as well as medical providers looking to offer advanced CryoAesthetics® solutions.
Features
- Customizable CryoAesthetics® treatment using precision cooling technology
- Three distinct modalities for tailored treatment plans
- Clinically-proven efficacy in reducing inflammation and improving skin conditions
- Precise temperature and duration control based on individual patient biology